<- Go Home

iCAD, Inc.

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Market Cap

$47.6M

Volume

187.7K

Cash and Equivalents

$17.2M

EBITDA

-$5.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$17.0M

Profit Margin

86.78%

52 Week High

$3.78

52 Week Low

$1.18

Dividend

N/A

Price / Book Value

1.61

Price / Earnings

-8.21

Price / Tangible Book Value

2.28

Enterprise Value

$30.7M

Enterprise Value / EBITDA

-5.90

Operating Income

-$6.1M

Return on Equity

18.09%

Return on Assets

-9.63

Cash and Short Term Investments

$17.2M

Debt

$362.0K

Equity

$28.7M

Revenue

$19.6M

Unlevered FCF

-$3.3M

Sector

Health Care Technology

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches